Literature DB >> 9078298

Monosomy X as a recurring sole cytogenetic abnormality associated with myelodysplastic diseases.

E Abruzzese1, P N Rao, M Slatkoff, J Cruz, B L Powell, B Jackle, M J Pettenati.   

Abstract

Solitary loss of the X chromosome is associated with Turner syndrome and not hematological disorders. We describe five patients with non-constitutional loss of the X chromosome as the sole cytogenetic abnormality in their bone marrow. Three of the five patients had myelodysplastic syndrome (MDS), one case had AML M-6 with evidence suggestive of an evolving MDS, and the last patient had a dysplastic marrow. A review of the literature identified sporadic reports of an association of monosomy X and several hematologic disorders, as well as a few solid tumors. In this series of patients, monosomy X as a sole non-constitutional cytogenetic abnormality in bone marrow is associated with myelodysplastic diseases. In addition, fluorescence in situ hybridization analysis with an X centromere probe indicated that monosomy X was present in erythroid precursors, myeloblasts, promyelocytes, myelocytes, metamyelocytes, granulocytes, and monocytes, while mature lymphocytes presented with two copies of the X chromosome. The molecular cytogenetic evidence supports the diagnosis of a myelodysplastic disorder in these cases and documents the potential role of FISH in hematological disease.

Entities:  

Mesh:

Year:  1997        PMID: 9078298     DOI: 10.1016/s0165-4608(97)83556-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension.

Authors:  Micheala A Aldred; Suzy A Comhair; Marileila Varella-Garcia; Kewal Asosingh; Weiling Xu; George P Noon; Patricia A Thistlethwaite; Rubin M Tuder; Serpil C Erzurum; Mark W Geraci; Christopher D Coldren
Journal:  Am J Respir Crit Care Med       Date:  2010-06-25       Impact factor: 21.405

Review 2.  The spectrum of sex differences in cancer.

Authors:  Joshua B Rubin
Journal:  Trends Cancer       Date:  2022-02-18

Review 3.  Rare cytogenetic abnormalities in myelodysplastic syndromes.

Authors:  Ulrike Bacher; Julie Schanz; Friederike Braulke; Detlef Haase
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-05-01       Impact factor: 2.576

Review 4.  The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications.

Authors:  Hassan Awada; Bicky Thapa; Valeria Visconte
Journal:  Cells       Date:  2020-11-20       Impact factor: 6.600

5.  Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms: a diagnostic dilemma for clinical cytogeneticists.

Authors:  Zhenya Tang; L Jeffrey Medeiros; C Cameron Yin; Wei Wang; Xinyan Lu; Ken H Young; Joseph D Khoury; Guilin Tang
Journal:  Mol Cytogenet       Date:  2016-08-08       Impact factor: 2.009

Review 6.  Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview.

Authors:  Mohammad Faizan Zahid; Umair Arshad Malik; Momena Sohail; Irfan Nazir Hassan; Sara Ali; Muhammad Hamza Saad Shaukat
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.